RxSight, Inc.
RXST
$5.55
$0.030.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 127.48M | 134.48M | 142.09M | 147.06M | 148.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 127.48M | 134.48M | 142.09M | 147.06M | 148.31M |
| Cost of Revenue | 29.30M | 31.47M | 35.55M | 39.53M | 41.72M |
| Gross Profit | 98.18M | 103.01M | 106.53M | 107.53M | 106.59M |
| SG&A Expenses | 115.88M | 112.66M | 113.25M | 111.51M | 106.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 182.83M | 182.67M | 187.57M | 189.59M | 185.17M |
| Operating Income | -55.35M | -48.19M | -45.48M | -42.53M | -36.86M |
| Income Before Tax | -46.59M | -38.88M | -35.66M | -32.18M | -26.49M |
| Income Tax Expenses | 53.00K | 65.00K | 72.00K | 75.00K | 59.00K |
| Earnings from Continuing Operations | -46.64 | -38.94 | -35.73 | -32.25 | -26.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.64M | -38.94M | -35.73M | -32.25M | -26.55M |
| EBIT | -55.35M | -48.19M | -45.48M | -42.53M | -36.86M |
| EBITDA | -52.02M | -44.93M | -42.55M | -39.32M | -33.63M |
| EPS Basic | -1.14 | -0.95 | -0.88 | -0.80 | -0.67 |
| Normalized Basic EPS | -0.71 | -0.59 | -0.55 | -0.50 | -0.42 |
| EPS Diluted | -1.14 | -0.95 | -0.88 | -0.80 | -0.67 |
| Normalized Diluted EPS | -0.71 | -0.59 | -0.55 | -0.50 | -0.42 |
| Average Basic Shares Outstanding | 164.19M | 163.39M | 162.58M | 161.40M | 159.11M |
| Average Diluted Shares Outstanding | 164.19M | 163.39M | 162.58M | 161.40M | 159.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |